| This week's sponsor is Premier Research. | |  | Rare Cancer Drug Research: What to Know Going In
Rare cancer drug research requires oncology and rare disease expertise and careful attention to trial design and regulatory demands. Get started with our white paper. Premier Research. It's what we do. Best. |
Today's Rundown Featured Story | | | Thursday, June 21, 2018 No fewer than five biotech IPOs debuted Thursday, raising more than $460 million and with more in the offing if underwriters take up further options. |
|
|
| This week's sponsor is Catalent. | |  | |
Top Stories Thursday, June 21, 2018 BrainStorm Cell Therapeutics is considering providing an experimental therapy to amyotrophic lateral sclerosis patients under the recently passed U.S. right-to-try law, Bloomberg reports. The Israeli biotech would expect to generate modest profits from the initiative, making it a test case for whether the law has turned unproven drugs into semicommercial products. Thursday, June 21, 2018 Molecular Partners has rejigged its leadership team, hiring Pamela Trail, Ph.D., from Regeneron to serve as CSO and shunting Michael Stumpp, Ph.D., across to the COO position. Monday, June 18, 2018 This informative eBook explores technology currently being used to improve clinical trial efficiency, while also offering a peek into the emerging technologies that will shape the future success of clinical trials. Thursday, June 21, 2018 Heron Therapeutics posted new positive results for its long-acting anesthetic for postoperative pain, HTX-011, this time from two phase 2 studies demonstrating effectiveness following total knee replacement and breast augmentation surgeries. Thursday, June 21, 2018 Kalytera is developing cannabidiol for the prevention and treatment of graft-versus-host disease, a serious complication of bone marrow transplant. It plans to enter phase 3 for the latter indication by the end of the year. Thursday, June 21, 2018 Puma's former senior director of regulatory affairs made more than $1 million by trading on nonpublic information, authorities say. Enrollment Showcase | | | Sponsored by: Bioinformatics at UTHealth SBMI UTHealth SBMI now offers a M.S. track in clinical and translational bioinformatics. |
|
|
Resources Life Science Strategy Group Take this anonymous 10-minute survey to share your thoughts on leading eClinical technology solutions and earn up to $55 honoraria. Take the survey now! Sponsored by: Blue Latitude Health Blue Latitude Health explores the commercial barriers and new stakeholder connections for pharma companies developing precision medicines, and reveals how to grasp novel opportunities in the new era of healthcare. Presented By: Covance A solid RBM plan will not only help you comply with the ICH guidelines, but will help you mitigate risks which could ultimately delay your trials and increase costs. Download today! Presented by: Patheon, part of Thermo Fisher Scientific “Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. |
|
